MBX Microbix Biosystems

Ontario Helps Microbix Ensure Provincial COVID Testing Capacity

Ontario Helps Microbix Ensure Provincial COVID Testing Capacity
EN
13/10/2020

Underlying

MBXMicrobix Biosystems

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Microbix Biosystems

 PRESS RELEASE
Free
MBX Microbix Biosys...

Microbix Reports Results for Q4 and Fiscal 2025

Microbix Reports Results for Q4 and Fiscal 2025 Full-Year Revenues of $18.6 million and Net Loss of $2.2 million MISSISSAUGA, Ontario, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its fiscal year and fourth quarter ended September 30, 2025 (“2025” and “Q4”) with revenues for those periods reflecting reduced antigen sales into China and cancellation of a client instrument and assay development program. Management DiscussionMicrobix added to both its capabilities ...

December 18, 2025 1 EN
 PRESS RELEASE
Free
MBX Microbix Biosys...

Microbix Schedules Release of Results for Q4 Fiscal 2025

Microbix Schedules Release of Results for Q4 Fiscal 2025 Results Release and Webinar Discussion on Morning of December 18, 2025 MISSISSAUGA, Ontario, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces that it expects to file the financial statements, management disclosure and analysis, and results news release for its fourth quarter of fiscal 2025 ended September 30, 2025 (“Q4 2025”) prior to the start of trading on December 18, 2025. At 10:00 AM ET that day, Microbix intends to...

December 11, 2025 1 EN
 PRESS RELEASE
Free
MBX Microbix Biosys...

Microbix Launches New Products to Support H3N2 Flu Testing

Microbix Launches New Products to Support H3N2 Flu Testing Test-Controls & Reference Materials for Labs & Test-Makers MISSISSAUGA, Ontario, Dec. 10, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, announces the commercial launch of QAPs™ quality assessment products and availability of QUANTDx™ reference materials to support antigen or molecular tests for H3N2 strains of seasonal Influenza A (a.k.a., the “Flu”). H3N2, alongside H1N1, is a common type of Influenza A that circulates annually, wit...

December 10, 2025 1 EN
 PRESS RELEASE
Free
MBX Microbix Biosys...

Microbix Announces Initiation of Normal Course Issuer Bid

Microbix Announces Initiation of Normal Course Issuer Bid For Repurchase of up to 5% of its outstanding shares over 12 months MISSISSAUGA, Ontario, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®) (“Microbix” or the “Company”), a life sciences innovator, manufacturer, and exporter, announces the initiation of a Normal Course Issuer Bid (“NCIB”) program for the repurchase and cancellation of outstanding common shares. Specifically, the NCIB enables Microbix to repurchase up to 6,949,346 Common Shares ("Shares"), that number being approximate...

December 4, 2025 1 EN
 PRESS RELEASE
Free
MBX Microbix Biosys...

Microbix & Seegene Mexico Collaborate to Improve Test Accuracy

Microbix & Seegene Mexico Collaborate to Improve Test Accuracy Making HPV Tests & Quality Assessment Products Available across Mexico MISSISSAUGA, Ontario and MEXICO CITY, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, and Seegene Mexico S.A.P.I. de C.V. (Seegene Mexico), a firm focused upon transforming molecular diagnostics with innovative multiplex solutions, announce that Microbix external third-party quality assessment products (QAPs®) will be used to support the clinical use of ...

December 3, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch